Ceftriaxone Monotherapy in the Treatment of Low-Risk Febrile Neutropenia

Abstract

Ceftriaxone is effective in febrile neutropenia. Treatment with ceftriaxone alone was safe and highly effective in low-risk patients. Single-agent regimens appear to be a suitable treatment option in low-risk febrile neutropenia.